Van Onvervulde Nood naar Besluitvorming: Empirische en Conceptuele Inzichten in het Farmaceutisch Beleid in Europa

Summarise with VIRAT
Authors: Zilke Claessens
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The concept of unmet medical needs is been used in, and beyond, regulatory and market access practices, determining the eligibility of innovative therapeutics in pathways for accelerated market access. These pathways are developed to speed up market access for products meeting the most pressing needs but what are the highest needs? No generally accepted understanding or definition of the unmet medical need concept is available. This complicates its application in guiding decision-making and impeding a clear signal for drug developers. In this Ph.D. project, we want to assess and align stakeholders' understanding of the concept of unmet medical needs via a combination of qualitative studies, including interactions with different stakeholders (including policymakers, regulatory authorities, developers, payers/HTA bodies, patients, and healthcare providers), and quantitative studies, such as surveys and analysis of market data and policy documents. Based on these multi-stakeholder insights we aim to formulate policy recommendations and develop tools and guidance that can support stakeholders in their decision-making process and contribute to a drug evaluation framework that drives and supports the industry to meet the most pressing unmet medical needs.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Health Systems Economic Evaluations Quality of Life Biomedical Ethics and Regulation

Publication details

Journal / source
Lirias
Publication date
13 March 2026
Language
EN
Document type
Thesis